Home › Funds › Ascentis Independent Advisors › ABBV

Ascentis Independent Advisors position in ABBV

ABBVIE INC · Health Care

Ascentis Independent Advisors reported holding 35,861 shares of ABBV (ABBVIE INC) in its Q3 2026 13F filing — a position valued at US$9.4M, representing 0.55% of its reported portfolio and ranking #29 among its reported holdings. Ascentis Independent Advisors has disclosed ABBV holdings in 12 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)35.86K sh
Reported value held$9.39M
Portfolio Weight0.55%
First reportedQ3 2023
Last changeAdd
Updated2026-11-04

Last updated: 2026-11-04 · Source: SEC EDGAR Form 13F-HR

How Ascentis Independent Advisors's ABBV position evolved

Ascentis Independent Advisors first disclosed a stake in ABBV in Q3 2023 at 16,827 shares (US$2.5M). The position peaked in Q3 2026 at 35,861 shares, worth US$9.4M. Across 12 filings, Ascentis Independent Advisors increased the stake 4 time(s), trimmed it 5 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 35,861 shares valued at US$9.4M — an increase of 35,083 shares quarter over quarter.. Notable position changes include a 256% increase in Q4 2024 (shares rose 19% over the following quarter), a 98% trim in Q2 2026 (shares rose 5% over the following quarter), a 4509% increase in Q3 2026 (shares rose 9% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 16.83K $2.51M New
Q4 2023 16.57K $2.57M Reduce
Q2 2024 16.58K $2.84M Hold
Q3 2024 5.77K $1.14M Reduce
Q4 2024 20.55K $3.65M Add
Q1 2025 20.19K $4.23M Reduce
Q2 2025 20.25K $3.76M Hold
Q3 2025 17.11K $3.96M Reduce
Q4 2025 19.84K $4.53M Add
Q1 2026 36.79K $8.00M Add
Q2 2026 778 $195.77K Reduce
Q3 2026 35.86K $9.39M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 35 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$29.04B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has Ascentis Independent Advisors held ABBV?

Ascentis Independent Advisors has disclosed ABBV holdings in 12 of the last 13 reported quarters, going back to Q3 2023.

What is Ascentis Independent Advisors's current position in ABBV?

As of Q3 2026, Ascentis Independent Advisors holds 35.86K shares of ABBV (ABBVIE INC), valued at $9.39M, representing 0.55% of its reported portfolio and ranking #29.

Has Ascentis Independent Advisors been buying or selling ABBV?

In the latest 13F filing (Q3 2026), Ascentis Independent Advisors increased its position in ABBV. The position peaked in Q3 2026 at 35.86K shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.